checkAd

     157  0 Kommentare Evolva signs multi-year agreement with leading CMO partner to enable supply of Vanillin to global F&F customer of around CHF 35 million until 2026

    Evolva Holding SA / Key word(s): Agreement
    Evolva signs multi-year agreement with leading CMO partner to enable supply of Vanillin to global F&F customer of around CHF 35 million until 2026

    05-May-2023 / 07:00 CET/CEST
    Release of an ad hoc announcement pursuant to Art. 53 LR
    The issuer is solely responsible for the content of this announcement.


    PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR
     

    Evolva signs multi-year agreement with leading CMO partner to enable supply of Vanillin to global F&F customer of around CHF 35 million until 2026

    Reinach, 5 May 2023 — Evolva (SIX: EVE), a pioneer in the field of natural molecules and industrial biotech, has reached a major milestone to boost its commercial performance by signing a multi-year agreement with a leading CMO partner as basis to secure the Vanillin business with a global F&F customer of around CHF 35 million until 2026.

    Thanks to its proprietary precision-fermentation platform and the newly signed CMO agreement, Evolva is now able to supply Vanillin to a global customer in the Flavors & Fragrances industry (F&F) within a framework of defined volumes and very competitive pricing over a multi-year period. The move is a further testimony to Evolva’s core capabilties of having successfully developed and upscaled high-grade Vanillin from lab to industrial scale production and now towards full commercialization.

    Based on the newly signed agreement with the selected CMO partner, Evolva expects to generate revenues of around CHF 35 million over the next three and a half years from supplying a global customer with Vanillin for use as natural ingredient to the flavors industry. As such, the agreement further substantiates Evolva’s mid-term plan.

    In 2023, the corresponding revenues are expected to be in the mid-single digit range. For production reasons, these revenues will fully accrue in the second half of the year, leading to a shift in revenues from the first to the second half of the year when compared to 2022.

    Vanillin is a widely used ingredient in the F&F industry. When plant derived, it is only available in limited quantities and often subject to price and supply fluctuations as crop yields are heavily dependent on climate conditions. Thanks to its proprietary precision-fermentation platform, Evolva is able to offer nature-based, high-grade Vanillin of European origin with a superior sensory profile at very attractive conditions. This allows customers to replace expensive vanilla bean extracts as well as synthetic vanillin (which is obtained through a chemical process), meeting the increasing demand of consumers for more natural ingredients which are responsibly and sustainably produced.

    Seite 1 von 3


    Diskutieren Sie über die enthaltenen Werte


    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    Evolva signs multi-year agreement with leading CMO partner to enable supply of Vanillin to global F&F customer of around CHF 35 million until 2026 Evolva Holding SA / Key word(s): Agreement Evolva signs multi-year agreement with leading CMO partner to enable supply of Vanillin to global F&F customer of around CHF 35 million until 2026 05-May-2023 / 07:00 CET/CEST Release of an ad hoc …